Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.

C. L. Vogel, R. Comis, J. L. Ziegler, J. W. Kiryabwire

Research output: Contribution to journalArticle

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)143-149
Number of pages7
JournalCancer chemotherapy reports. Part 1
Volume55
Issue number2
StatePublished - Apr 1 1971
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this